115 related articles for article (PubMed ID: 580956)
1. A new approach to the problem of retinal neovascularization.
Patz A; Brem S; Finkelstein D; Chen CH; Lutty G; Bennett A; Coughlin WR; Gardner J
Ophthalmology; 1978 Jun; 85(6):626-37. PubMed ID: 580956
[TBL] [Abstract][Full Text] [Related]
2. Experimental retinal neovascularization induced by intravitreal tumors.
Finkelstein D; Brem S; Patz A; Folkman J; Miller S; Ho-Chen C
Am J Ophthalmol; 1977 May; 83(5):660-4. PubMed ID: 868966
[TBL] [Abstract][Full Text] [Related]
3. Observations on retinal neovascularization.
Patz A
Trans New Orleans Acad Ophthalmol; 1983; 31():82-8. PubMed ID: 6194596
[No Abstract] [Full Text] [Related]
4. Studies on retinal neovascularization. Friedenwald Lecture.
Patz A
Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1133-8. PubMed ID: 6158493
[TBL] [Abstract][Full Text] [Related]
5. Effect of oxygen tension on the quantities of procollagenase-activating angiogenic factor present in the developing kitten retina.
Taylor CM; Weiss JB; Kissun RD; Garner A
Br J Ophthalmol; 1986 Mar; 70(3):162-5. PubMed ID: 2420354
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic activity of vitreous and retinal extract.
Chen CH; Chen SC
Invest Ophthalmol Vis Sci; 1980 Jun; 19(6):596-602. PubMed ID: 6155359
[No Abstract] [Full Text] [Related]
7. Prolonged tumor dormancy by prevention of neovascularization in the vitreous.
Brem S; Brem H; Folkman J; Finkelstein D; Patz A
Cancer Res; 1976 Aug; 36(8):2807-12. PubMed ID: 1277191
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neovascularization by an extract derived from vitreous.
Preis I; Langer R; Brem H; Folkman J
Am J Ophthalmol; 1977 Sep; 84(3):323-8. PubMed ID: 900228
[TBL] [Abstract][Full Text] [Related]
9. [Retrolental fibroplasia: physiopathologic concepts in 1984].
Lacaule F; Le Rebeller MJ
Bull Soc Ophtalmol Fr; 1985; 85(6-7):807-9. PubMed ID: 2421933
[No Abstract] [Full Text] [Related]
10. Hemorheological changes in experimental retrolental fibroplasia.
Lemmingson W
Biorheology; 1976 Apr; 13(2):97-9. PubMed ID: 947214
[No Abstract] [Full Text] [Related]
11. Treatment of acute proliferative retrolental fibroplasia.
Payne JW; Patz A
Trans Am Acad Ophthalmol Otolaryngol; 1972; 76(5):1234-46. PubMed ID: 4679275
[No Abstract] [Full Text] [Related]
12. Retrolental fibroplasia: a new look at an unsolved problem.
Johnson L
Hosp Pract (Off Ed); 1981 May; 16(5):109-15, 118-20, 121. PubMed ID: 6785184
[No Abstract] [Full Text] [Related]
13. Hypoxia-induced retinal neovascularization in zebrafish embryos: a potential model of retinopathy of prematurity.
Wu YC; Chang CY; Kao A; Hsi B; Lee SH; Chen YH; Wang IJ
PLoS One; 2015; 10(5):e0126750. PubMed ID: 25978439
[TBL] [Abstract][Full Text] [Related]
14. Clinical and experimental studies on retinal neovascularization. XXXIX Edward Jackson Memorial Lecture.
Patz A
Am J Ophthalmol; 1982 Dec; 94(6):715-43. PubMed ID: 6184997
[TBL] [Abstract][Full Text] [Related]
15. Vitreous: an inhibitor of retinal extract-induced neovascularization.
Lutty GA; Thompson DC; Gallup JY; Mello RJ; Patz A; Fenselau A
Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):52-6. PubMed ID: 6186631
[TBL] [Abstract][Full Text] [Related]
16. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy.
Chen J; Connor KM; Aderman CM; Willett KL; Aspegren OP; Smith LE
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1329-35. PubMed ID: 18952918
[TBL] [Abstract][Full Text] [Related]
17. The role of lactic acid in retinal neovascularization.
Gerke E; Spitznas M; Brodde OE
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1976 Jul; 200(1):79-84. PubMed ID: 1085580
[TBL] [Abstract][Full Text] [Related]
18. Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.
McLeod DS; Taomoto M; Cao J; Zhu Z; Witte L; Lutty GA
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):474-82. PubMed ID: 11818393
[TBL] [Abstract][Full Text] [Related]
19. Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity.
Zhang W; Ito Y; Berlin E; Roberts R; Berkowitz BA
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3119-23. PubMed ID: 12824260
[TBL] [Abstract][Full Text] [Related]
20. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
